Form 8-K - Current report:
SEC Accession No. 0001213900-13-001911
Filing Date
2013-04-17
Accepted
2013-04-17 17:14:36
Documents
21
Period of Report
2013-04-11
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k041113_actinium.htm 8-K 28141
2 DELAWARE CERTIFICATE OF INCORPORATION FOR ACTINIUM PHARMACEUTICALS, INC. f8k041113ex3i_actinium.htm EX-3.1 2757
3 BYLAWS FOR ACTINIUM PHARMACEUTICALS, INC. f8k041113ex3ii_actinium.htm EX-3.2 98242
4 DELAWARE CERTIFICATE OF MERGER f8k041113ex3iii_actinium.htm EX-3.3 836
5 NEVADA ARTICLES OF MERGER f8k041113ex3iv_actinium.htm EX-3.4 8922
6 PRESS RELEASE DATED APRIL 17, 2013 f8k041113ex99i_actinium.htm EX-99.1 18218
7 ex99i.jpg GRAPHIC 18735
8 ex3iii.jpg GRAPHIC 109662
9 ex3iv_1.jpg GRAPHIC 79988
10 ex3iv_2.jpg GRAPHIC 72576
11 ex3iv_3.jpg GRAPHIC 56383
12 ex3iv_4.jpg GRAPHIC 55401
13 ex3iv_5.jpg GRAPHIC 69815
14 ex3iv_6.jpg GRAPHIC 86036
15 ex3iv_7.jpg GRAPHIC 103862
16 ex3iv_8.jpg GRAPHIC 123466
17 ex3iv_9.jpg GRAPHIC 130123
18 ex3iv_10.jpg GRAPHIC 97437
19 ex3i_1.jpg GRAPHIC 129913
20 ex3i_2.jpg GRAPHIC 132379
21 ex3i_3.jpg GRAPHIC 32281
  Complete submission text file 0001213900-13-001911.txt   1948518
Mailing Address 501 FIFTH AVENUE, 3RD FLOOR NEW YORK NY 10017
Business Address 501 FIFTH AVENUE, 3RD FLOOR NEW YORK NY 10017 212-300-2131
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-52446 | Film No.: 13767544
SIC: 6770 Blank Checks